By Mill Chart
Last update: May 17, 2025
EXELIXIS INC (NASDAQ:EXEL) has been identified as a high-growth momentum stock that also aligns with Mark Minervini’s Trend Template criteria. The company, focused on developing oncology treatments, demonstrates both technical strength and robust fundamental growth, making it a compelling candidate for investors seeking high-growth opportunities.
Minervini’s strategy emphasizes stocks in strong uptrends with clear technical strength. EXEL meets these criteria:
Price Above Key Moving Averages:
Upward-Trending Moving Averages:
Strong Relative Strength:
Price Near 52-Week High:
Beyond technicals, EXEL exhibits strong growth metrics:
Earnings Growth:
Revenue Expansion:
Profitability Improvements:
Analyst Confidence:
EXEL’s technical rating of 10/10 reflects its strong uptrend, high relative strength, and consistent performance. However, the setup rating of 2/10 suggests the stock may be extended in the short term, indicating a potential consolidation before another breakout.
For a deeper technical analysis, review the full EXEL technical report.
Our High Growth Momentum + Trend Template screener lists more stocks meeting these criteria.
This is not investment advice. Always conduct your own research before making investment decisions.
45.72
+2.35 (+5.42%)
Find more stocks in the Stock Screener
EXELIXIS INC (NASDAQ:EXEL) shows strong growth momentum and meets Minervini’s trend criteria, making it a stock to watch for high-growth investors.
Wondering what's happening in Monday's pre-market session? Find an overview in this article.
EXELIXIS INC (NASDAQ:EXEL) meets key growth investing criteria with strong earnings, revenue growth, and profitability, making it a standout for investors following Louis Navellier's strategy.
EXELIXIS INC (NASDAQ:EXEL) offers strong growth, solid profitability, and reasonable valuation, making it a compelling choice for investors seeking affordable growth stocks in the biotech sector.
EXELIXIS INC (NASDAQ:EXEL) is an undervalued biotech stock with strong profitability, growth, and financial health, making it a compelling pick for value investors.
EXELIXIS INC (NASDAQ:EXEL) combines strong earnings momentum with a high technical rating, making it a standout for growth investors. The stock's breakout setup suggests potential upside.